Hexoskin (Carré Technologies)

Hexoskin, founded in 2006 in Montreal by Pierre-Alexandre Fournier, is a leader in non-invasive wearable sensors, software, and AI-driven health solutions.

Reviewed by 7wData
Share Email

On this page

Profile

Hexoskin develops wearable sensors and AI software for health monitoring and diagnostics.

Hexoskin, founded in 2006 in Montreal by Pierre-Alexandre Fournier, is a leader in non-invasive wearable sensors, software, and AI-driven health solutions. The company specializes in developing medical-grade wearables and algorithms for health monitoring and diagnostics. Hexoskin’s flagship products, Hexoskin and Astroskin, are used in clinical research, defense, and aerospace markets.

The company has raised $4.2M in additional funding in August 2024 to accelerate its clinical AI development platform. Hexoskin’s smart shirts are trusted by organizations in over 50 countries, including CSA, NASA, and DOD, and have been used in over 250 scientific publications. The company’s technology has been deployed on the International Space Station since 2019, supporting critical research on human health in space.

Hexoskin’s software and wearable sensors are also utilized in clinical trials for cardiac, respiratory, and rare diseases. The company’s recent funding round includes investments from AQC Capital, Anges Quebec, BDC Capital, and Deep Divers Ltd. Hexoskin’s focus on high-resolution digital measures and biomarkers positions it uniquely in the digital health market.

Track Hexoskin (Carré Technologies) and 240+ vendors.

335k+ subscribers read the daily AI & data note. One email, both newsletters. Unsubscribe anytime.

Who buys this

  • Clinical research teams
  • Defense and aerospace organizations
  • Pharmaceutical companies
  • Healthcare providers
  • Academic institutions

Publicly disclosed clients

  • CSA
  • NASA
  • DOD
  • Yale Health
  • Boston Children's Hospital

Strengths and what to watch

Strengths

  • Over 15 years of experience in clinical AI development
  • Trusted by leading organizations like NASA and CSA
  • Over 250 scientific publications using Hexoskin data

Watch for

  • High dependency on clinical research funding
  • Competition from other wearable tech companies
  • Regulatory challenges in medical device approvals

Key Information

Founded
2006
Headquarters
Montreal

Frequently Asked Questions

What is Hexoskin and what does it do?

Hexoskin develops medical-grade wearable sensors and AI software for health monitoring and diagnostics. Founded in 2006, its smart shirts and algorithms are used in clinical research, aerospace, and defense, with clients like NASA and CSA. The technology supports cardiac, respiratory, and rare disease studies.

How accurate are Hexoskin's wearable health sensors?

Hexoskin's wearables are medical-grade, validated in over 250 scientific publications. Used by NASA on the ISS since 2019, they provide high-resolution biometric data for cardiac, respiratory, and neurological monitoring. The FDA-cleared devices meet clinical research standards for reliability.

Which organizations use Hexoskin's technology?

Hexoskin serves NASA, CSA, DOD, Yale Health, and Boston Children's Hospital. Its wearables are deployed in 50+ countries for clinical trials, aerospace research, and hospital care. The technology is cited in 250+ studies, including ISS health monitoring since 2019.

What makes Hexoskin different from other wearable tech companies?

Hexoskin specializes in non-invasive, medical-grade wearables with 15+ years of clinical AI development. Unlike consumer fitness trackers, its FDA-cleared devices focus on precise diagnostics, backed by NASA and pharmaceutical research. The $4.2M 2024 funding accelerates its AI platform for biomarkers.

Can Hexoskin's smart shirts monitor respiratory health?

Yes, Hexoskin's shirts track respiratory metrics like breathing rate and tidal volume, used in pulmonary studies. The sensors are non-adhesive and flexible, making them ideal for long-term monitoring in clinical trials and space missions, as featured in ISS research.

How is Hexoskin advancing AI in health diagnostics?

Hexoskin combines wearable sensors with AI algorithms to analyze cardiac, respiratory, and neurological data. Its 2024 funding focuses on clinical AI development, enhancing digital biomarkers for diseases. Partners like Mayo Clinic use this for research, cited in 250+ publications.

Sources

  1. hexoskin.com — Hexoskin raised $4.2M in additional funding in August 2024.
  2. hexoskin.com — Hexoskin’s mission and product portfolio.
  3. hexoskin.com — Hexoskin’s focus on respiratory health applications.
  4. hexoskin.com — Hexoskin’s involvement in neurological research.